Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries

International Journal of Cancer. Journal International Du Cancer
Shu-Chun ChuangMia Hashibe

Abstract

The objective of the study was to assess the risk of second primary cancers (SPCs) following a primary head and neck cancer (oral cavity, pharynx and larynx) and the risk of head and neck cancer as a SPC. The present investigation is a multicenter study from 13 population-based cancer registries. The study population involved 99,257 patients with a first primary head and neck cancer and contributed 489,855 person-years of follow-up. To assess the excess risk of SPCs following head and neck cancers, we calculated standardized incidence ratios (SIRs) by dividing the observed numbers of SPCs by the expected number of cancers calculated from accumulated person-years and the age-, sex- and calendar period-specific first primary cancer incidence rates in each of the cancer registries. During the observation period, there were 10,826 cases of SPCs after head and neck cancer. For all cancer sites combined, the SIR of SPCs was 1.86 (95% CI = 1.83-1.90) and the 20-year cumulative risk was 36%. Lung cancer contributed to the highest proportion of the SPCs with a 20-year cumulative risk of 13%. Excess second head and neck cancer risk was observed 10 years after diagnosis with lymphohaematopoietic cancers. The most common SPC following a fi...Continue Reading

References

Feb 1, 1992·The Annals of Otology, Rhinology, and Laryngology·B H HaugheyJ Harvey
Jan 26, 1991·BMJ : British Medical Journal·G R Ogden
Sep 1, 1968·The Journal of the American Dental Association·S G Castigliano
Dec 1, 1995·The Annals of Otology, Rhinology, and Laryngology·E M Sturgis, R H Miller
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Berrino, G Gatta
Apr 20, 1999·Head & Neck·X LeónJ Burgués
Feb 13, 2003·American Journal of Otolaryngology·Michael S Tomek, W Frederick McGuirt
Jul 19, 2003·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Pedro VaamondeTorcuato LaBella
Dec 20, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SantUNKNOWN EUROCARE Working Group
Jun 23, 2005·British Journal of Cancer·P BrennanP Boffetta
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Ghislaine ScéloPaul Brennan
Jul 14, 2005·Current Opinion in Otolaryngology & Head and Neck Surgery·David P Goldstein, Jonathan C Irish
Feb 4, 2006·The Lancet Oncology·Paolo Boffetta, Mia Hashibe
Oct 24, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lois B Travis
Jan 24, 2007·Cancer Causes & Control : CCC·Ghislaine ScéloPaul Brennan
Jul 28, 2007·Head & Neck·Camille C Rose Ragin, Emanuela Taioli

❮ Previous
Next ❯

Citations

Feb 18, 2011·Cancer Causes & Control : CCC·Luc G T MorrisIan Ganly
Jan 15, 2011·Current Oncology Reports·Antonio Vitor Martins PrianteLuiz Paulo Kowalski
Aug 21, 2010·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·D Gregory FarwellPeter C Belafsky
Jul 9, 2010·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Chen-Shuan ChungHsiu-Po Wang
Apr 1, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·X ShuK Hemminki
Feb 9, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Pierre Benoit PagèsMarc Riquet
Mar 24, 2012·American Journal of Clinical Oncology·Subhankar ChakrabortyRalph J Hauke
Mar 18, 2010·Current Opinion in Otolaryngology & Head and Neck Surgery·Patrick J Bradley, Paula T Bradley
Dec 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luc G T MorrisIan Ganly
Feb 27, 2009·Future Oncology·Julia A Woolgar, Gillian L Hall
Feb 18, 2014·BMC Cancer·Jérémie JéguMichel Velten
Jul 9, 2013·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Xavier LeónMiquel Quer
Oct 19, 2013·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Antonio Vitor Martins PrianteLuiz Paulo Kowalski
Aug 31, 2013·Surgery Today·Masaru MoritaYoshihiko Maehara
Jan 12, 2010·Cancer Epidemiology·Virve KoljonenEero Pukkala
Mar 19, 2014·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·M BloebaumP Kessler
Nov 6, 2012·Current Medical Research and Opinion·Jonessa Ann S Atienza, Constantin A Dasanu
Dec 18, 2013·Seminars in Oncology·Kevin C OeffingerChaya S Moskowitz
Jan 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Keith R UngerK William Harter
Dec 17, 2015·American Journal of Respiratory and Critical Care Medicine·Stephen Lam, Eva Szabo
Dec 15, 2015·Best Practice & Research. Clinical Gastroenterology·Chen-Shuan ChungMing-Shiang Wu
Jul 26, 2011·Periodontology 2000·Julia A Woolgar, Asterios Triantafyllou
May 27, 2010·International Journal of Cancer. Journal International Du Cancer·Lifang LiuIsabelle Soerjomataram
Jun 8, 2012·Cancer·Mieke Van HemelrijckPär Stattin
Nov 10, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·G ZhuY Zhang
Jul 14, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Erlend RennemoMorten Boysen
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Cristina BosettiPaolo Boffetta
Mar 24, 2016·CA: a Cancer Journal for Clinicians·Ezra E W CohenMandi L Pratt-Chapman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.